Inventor · disambiguated record
Liusheng Zhu
Also filed as: ZHU LIUSHENG
33 granted patents·12 pending applications·418 citations·filing 2000–2025
97Inventor score
Top patents by PatentIndex Score
45 records- 0196US11629136B1Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2022·Granted Apr 18, 2023·4 cites·29 claims
- 0296US11028120B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·10 cites·30 claims
- 0395US12018043B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·6 cites·33 claims
- 0495US11130778B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Sep 28, 2021·8 cites·30 claims
- 0595US7144903B2CCR4 antagonistsAMGEN INC·Filed 2002·Granted Dec 5, 2006·90 cites·44 claims
- 0695US6316503B1LXR modulatorsTULARIK INC·Filed 2000·Granted Nov 13, 2001·100 cites·47 claims
- 0794US11530236B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·4 cites·25 claims
- 0894US7582803B2Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2006·Granted Sep 1, 2009·17 cites·19 claims
- 0993US11970481B1Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2023·Granted Apr 30, 2024·4 cites·18 claims
- 1093US11325938B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·9 cites·20 claims
- 1192US12110285B2Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2023·Granted Oct 8, 2024·1 cites·19 claims
- 1292US7053215B2Substituted Quinazolin-4(3H)-one compounds, compositions, and methods for their useAMGEN SF LLC·Filed 2002·Granted May 30, 2006·47 cites·18 claims
- 1391US10100063B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2016·Granted Oct 16, 2018·8 cites·12 claims
- 1491US7067662B2CXCR3 antagonistsAMGEN SF LLC·Filed 2004·Granted Jun 27, 2006·31 cites·20 claims
- 1590US11945796B2Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2021·Granted Apr 2, 2024·2 cites·66 claims
- 1690US10472387B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Nov 12, 2019·2 cites·6 claims
- 1789US7816367B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Oct 19, 2010·15 cites·25 claims
- 1888US6884782B2STAT modulatorsAMGEN INC·Filed 2001·Granted Apr 26, 2005·23 cites·102 claims
- 1987US12454544B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2024·Granted Oct 28, 2025·0 cites·9 claims
- 2086US8030354B2Substituted biphenyl GPR40 modulatorsAMGEN INC·Filed 2008·Granted Oct 4, 2011·11 cites·96 claims
- 2185US11807658B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Nov 7, 2023·1 cites·19 claims
- 2285US7649110B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Jan 19, 2010·8 cites·37 claims
- 2383US8450522B2Conformationally constrained carboxylic acid derivatives useful for treating metabolic disordersBROWN SEAN P·Filed 2009·Granted May 28, 2013·9 cites·17 claims
- 2483US2025368677A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2581US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 2679US11124537B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·1 cites·23 claims
- 2778US7465804B2Compounds, pharmaceutical compositions and methods for their use in treating metabolic disordersAMGEN INC·Filed 2006·Granted Dec 16, 2008·3 cites·48 claims
- 2876US10723759B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·28 claims
- 2976US2023096870A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3076US2024124512A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3174US10836779B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted Nov 17, 2020·0 cites·8 claims
- 3273US8748462B2Spirocyclic GPR40 modulatorsBROWN SEAN P·Filed 2009·Granted Jun 10, 2014·2 cites·25 claims
- 3370US10836789B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·0 cites·30 claims
- 3469US2021017219A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3564US2009275598A1Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2009·Application pending·0 cites
- 3664US2021379084A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3763US12404265B2Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2021·Granted Sep 2, 2025·0 cites·16 claims
- 3863US2005101540A1STAT modulatorsAMGEN INC·Filed 2004·Application pending·0 cites
- 3961US2021395295A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4059US11110103B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 7, 2021·0 cites·12 claims
- 4146US2021122730A1Glucocorticoid receptor modulatorsORIC PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4246US2007244155A1Bicyclic carboxylic acid derivatives useful for treating metabolic disordersAMGEN INC·Filed 2007·Application pending·0 cites
- 4344US2007149557A1CXCR3 antagonistsAMGEN INC·Filed 2006·Application pending·0 cites
- 4444US2022079924A1Glucocorticoid receptor modulatorsORIC PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4542US11208432B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Dec 28, 2021·0 cites·35 claims
Join the waitlist — get patent alerts
Get an alert when Liusheng Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →